Market Tracker

04/28 5:16pm ET

C R Bard Inc (NYSE:BCR)

307.48
Delayed Data
As of Apr 28
 +1.90 / +0.62%
Today’s Change
203.63
Today|||52-Week Range
307.88
+36.86%
Year-to-Date
BCR Regular Dividend: BCR began trading ex-dividend on 04/27/17. A $0.26 dividend will be paid to shareholders of record as of 05/01/17.
Good Medicine Makes for 3 Good Charts
Apr 27 / TheStreet.com - Paid Partner Content
Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead
Apr 24 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More
Apr 25 / TheStreet.com - Paid Partner Content
Stock Market News for April 24, 2017
Apr 24 / Zacks.com - Paid Partner Content
Cramer: Sorry, Popeye, but Market Rally Isn't Just About the French Connection
Apr 24 / TheStreet.com - Paid Partner Content
C.R. Bard (BCR) Beats Q1 Earnings & Revenues, FY17 View Up
Apr 24 / Zacks.com - Paid Partner Content
Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)
Apr 24 / TheStreet.com - Paid Partner Content
Frontrunning: April 24
Apr 24 / Investing Channel - Paid Partner Content
Becton Dickinson: meeting expectations
Apr 24 / FT.com - Paid Partner Content
Becton Dickinson Acquires Medical Technology Peer C.R. Bard for Hefty Premium
Apr 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close305.58
Today’s open305.00
Day’s range305.00 - 307.88
Volume1,885,011
Average volume (3 months)746,739
Market cap$22.3B
Dividend yield0.34%
Data as of 4:02pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+297.18%
Earnings growth (this year)+14.13%
Earnings growth (next 5 years)+10.32%
Revenue growth (last year)+8.72%
P/E ratio43.7
Price/Sales4.55
Price/Book13.38

Competitors

 Today’s
change
Today’s
% change
ZBHZimmer Biomet Holdin...+1.55+1.31%
TFXTeleflex Inc+0.43+0.21%
BSXBoston Scientific Co...+0.20+0.76%
WSTWest Pharmaceutical ...-0.66-0.71%
Data as of 4:03pm ET, 04/28/2017

Financials

Last reporting dateApril 23, 2017
EPS forecast (this quarter)$2.65
Annual revenue (last year)$3.7B
Annual profit (last year)$528.8M
Net profit margin14.24%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Timothy M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts